2479 related articles for article (PubMed ID: 8199994)
1. Analysis of melanocytic lesions by DNA image cytometry.
Schmidt B; Weinberg DS; Hollister K; Barnhill RL
Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994
[TBL] [Abstract][Full Text] [Related]
2. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study.
Bruijn JA; Berwick M; Mihm MC; Barnhill RL
J Cutan Pathol; 1993 Apr; 20(2):121-5. PubMed ID: 8320355
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
4. Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions.
Grossniklaus HE; Oakman JH; Cohen C; Calhoun FP; DeRose PB; Drews-Botsch C
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):745-50. PubMed ID: 7890505
[TBL] [Abstract][Full Text] [Related]
5. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
6. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
[TBL] [Abstract][Full Text] [Related]
7. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
8. Nevomelanocytic atypia detection by in vivo reflectance confocal microscopy.
Vaišnorienė I; Rotomskis R; Kulvietis V; Eidukevičius R; Zalgevičienė V; Laurinavičienė A; Venius J; Didžiapetrienė J
Medicina (Kaunas); 2014; 50(4):209-15. PubMed ID: 25458957
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
11. Congenital melanocytic nevi and DNA content. An analysis by flow and image cytometry.
Barnhill RL; Aguiar M; Cohen C; Kang S; Kennedy J; Schmidt B; Sober AJ; Solomon AR
Cancer; 1994 Dec; 74(11):2935-43. PubMed ID: 7954257
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
Rhodes AR; Mihm MC; Weinstock MA
Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
Ribé A
J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
[TBL] [Abstract][Full Text] [Related]
14. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
[TBL] [Abstract][Full Text] [Related]
15. Prediction of histologic melanocytic dysplasia from clinical observation.
Roush GC; Dubin N; Barnhill RL
J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
17. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG
Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.
Williams RA; Baak JP; Meijer GA; Charlton IG
Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
